When was AllStripes founded?
AllStripes was founded in 2017.
Where is AllStripes's headquarters?
AllStripes's headquarters is located at 121 2nd Street, San Francisco.
What is AllStripes's latest funding round?
AllStripes's latest funding round is Unattributed VC.
How much did AllStripes raise?
AllStripes raised a total of $115M.
Who are the investors of AllStripes?
Investors of AllStripes include Lux Capital, Spark Capital, Jazz Venture Partners, Maveron, Medidata Solutions and 9 more.
Who are AllStripes's competitors?
Competitors of AllStripes include Syapse, Owkin, Mendel.ai, ConcertAI, TrialJectory, Verana Health, Holmusk, Ciitizen, Verantos, Aetion and 14 more.
You May Also Like
Verantos specializes in high accuracy real-world evidence (RWE) generation. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use. The Verantos RWE platform leverages data science and artificial intelligence along with advanced data sources to generate RWE capable of supporting clinical assertions.
Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.
Ignite Data helps access the right patients and data for UK clinical studies and database projects.
Motivation Science is the developer of Validic, a digital health platform that provides a simple connection to secure, standardized data from specialized digital health technologies, such as wellness applications, wearables, fitness equipment and clinical devices.
Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data. The firm was founded in 2017 and is based in San Francisco, California.
Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology. The company was founded in 2016 and is based in New York, New York.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.